Virpax Pharmaceuticals Pink Sheet Forecast - Polynomial Regression
| VRPXDelisted Stock | USD 0.25 0.04 19.05% |
The Polynomial Regression forecasted value of Virpax Pharmaceuticals on the next trading day is expected to be -0.23 with a mean absolute deviation of 0.32 and the sum of the absolute errors of 19.66. Virpax Pink Sheet Forecast is based on your current time horizon.
Virpax |
Virpax Pharmaceuticals Polynomial Regression Price Forecast For the 27th of July
Given 90 days horizon, the Polynomial Regression forecasted value of Virpax Pharmaceuticals on the next trading day is expected to be -0.23 with a mean absolute deviation of 0.32, mean absolute percentage error of 0.16, and the sum of the absolute errors of 19.66.Please note that although there have been many attempts to predict Virpax Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Virpax Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Virpax Pharmaceuticals Pink Sheet Forecast Pattern
| Backtest Virpax Pharmaceuticals | Virpax Pharmaceuticals Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Virpax Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Virpax Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.2613 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.3223 |
| MAPE | Mean absolute percentage error | 0.1819 |
| SAE | Sum of the absolute errors | 19.6576 |
Predictive Modules for Virpax Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Virpax Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Virpax Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Virpax Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Virpax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Virpax Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Virpax Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Virpax Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Virpax Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Virpax Pharmaceuticals pink sheet market strength indicators, traders can identify Virpax Pharmaceuticals entry and exit signals to maximize returns.
Virpax Pharmaceuticals Risk Indicators
The analysis of Virpax Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Virpax Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting virpax pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.51 | |||
| Standard Deviation | 11.36 | |||
| Variance | 129.16 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Virpax Pink Sheet
If you are still planning to invest in Virpax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virpax Pharmaceuticals' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |